Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination
about
Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistanceEvaluation of high-dose daptomycin for therapy of experimental Staphylococcus aureus foreign body infection.Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin.Development of daptomycin for gram-positive infections.Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections.What do we really know about antibiotic pharmacodynamics?Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin.Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremiaBactericidal activity of oxacillin and glycopeptides against Staphylococcus aureus in patients with endocarditis: looking for a relationship between tolerance and outcomeDaptomycin.Prophylactic use of vancomycin in adult cardiology and cardiac surgery.Beta-lactams versus glycopeptides in treatment of subcutaneous abscesses infected with Staphylococcus aureus.Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremiaPredictors of mortality in Staphylococcus aureus BacteremiaImpact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureusDaptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.Vancomycin-resistant enterococcal urinary tract infections.Efficacy of ticarcillin-clavulanic acid for treatment of experimental Staphylococcus aureus endocarditis in rats.In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin.Protracted and recurrent methicillin-resistant Staphylococcus aureus bacteremia despite defervescence with vancomycin therapy.Inappropriate vancomycin prescribing based on criteria from the Centers for Disease Control and Prevention.Antibiotic prophylaxis and the medically compromised patient.Lack of bactericidal antagonism or synergism in vitro between oxacillin and vancomycin against methicillin-susceptible strains of Staphylococcus aureus.Daptomycin: a novel agent for Gram-positive infections.Perioperative Antibiotics
P2860
Q28361569-70C86996-3072-46B0-9376-A6F2BD746452Q33239640-FD712EAB-E624-41E2-AAE6-16A46B878109Q33750776-DCE8EF0B-5166-43D4-A4C5-8E00716D3D34Q33920377-ACC69C97-E5E2-408E-82DF-830EAC7D6469Q34303042-52A2B2D4-1A85-439D-A3AE-0B7001CF486AQ34443407-2C52CBC8-E50A-4FFF-B276-7DE39D4DB8D8Q34721715-0B6C1BB1-0964-40CC-876B-FA9C0C7C808FQ34783668-38B8415A-2EAD-4FCD-9997-69D341DCC465Q35078077-97DB9F67-4875-4AC6-AFD6-B80F10F477B4Q35637066-B6C71721-AD24-4B10-9166-C0AA51A8BD44Q35750208-F1F1800A-1CDE-4C0C-B5D4-040C7A6FA0B5Q35820407-53A9B8D2-4B3B-4552-91AF-E78AA541C080Q35879117-C6A2EC91-4063-4178-BB69-B8B12AF70474Q35940556-4BDDA8DA-3947-4C08-8A61-13B19AD19659Q36095086-BC863127-9238-4FB6-AEAE-A9DF3EE1E58AQ36744825-1DB66CAC-3151-4814-ADEB-5065E7A7BF0AQ37802885-11EDD3DC-CA71-432B-9AAB-3B98FE54F277Q39867979-8315D709-3A9D-4996-B71F-34089158252EQ40088863-6CD58D66-E6F0-4689-8A3F-6EC1B546A608Q40690496-4B536B0A-0588-4CC6-8687-9F1E9054CB66Q40950966-53734F90-3A07-4DD1-AC79-044A806019BCQ41754792-9EB3D250-B92C-4359-99B9-ADB1368A815DQ42929761-4BD36648-5C11-49B0-A29D-CEDCC9F7EA50Q53852746-EDC49D72-997B-424E-969D-E9C89B2F6944Q56928143-7AFC9FD8-6211-4196-88DD-818BF8E2407C
P2860
Comparative efficacy of daptomycin, vancomycin, and cloxacillin for the treatment of Staphylococcus aureus endocarditis in rats and role of test conditions in this determination
description
1990 nî lūn-bûn
@nan
1990 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Comparative efficacy of daptom ...... nditions in this determination
@ast
Comparative efficacy of daptom ...... nditions in this determination
@en
type
label
Comparative efficacy of daptom ...... nditions in this determination
@ast
Comparative efficacy of daptom ...... nditions in this determination
@en
prefLabel
Comparative efficacy of daptom ...... nditions in this determination
@ast
Comparative efficacy of daptom ...... nditions in this determination
@en
P2093
P2860
P356
P1476
Comparative efficacy of daptom ...... nditions in this determination
@en
P2093
P2860
P304
P356
10.1128/AAC.34.12.2348
P407
P577
1990-12-01T00:00:00Z